The HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES)
View PDF - The HIV Treatment Adherence Self-Efficacy Scale (HIVASES)_Johnson.pdf
Johnson, M. O., Neilands, T. B., Dilworth, S. E., Morin, S. F., Remien, R. H., & Chesney, M. A. (2007). The role of self-efficacy in HIV treatment adherence: Validation of the HIV treatment adherence self-efficacy scale (HIV-ASES). Journal of Behavioral Medicine, 30(5), 359-370.
Reponses range from 1 (cannot do it at all) to 10 (certain can do it).
In the past month, how confident have you been that you can:
1. Stick to your treatment plan even when side effects begin to interfere with daily activities?
2. Integrate your treatment into your daily routine?
3. Integrate your treatment into your daily routine even if it means taking medication or doing other things in front of people who don’t know you are HIV-infected?
4. Stick to your treatment schedule even when your daily routine is disrupted?
5. Stick to your treatment schedule when you aren’t feeling well?
6. Stick to your treatment schedule when it means changing your eating habits?
7. Continue with your treatment even if doing so interferes with your daily activities?
8. Continue with the treatment plan your physician prescribed even if your T-cells drop significantly in the next three months?
9. Continue with your treatment even when you are feeling discouraged about your health?
10. Continue with your treatment even when getting to your clinic appointments is a major hassle?
11. Continue with your treatment even when people close to you tell you that they don’t think that it is doing any good?
12. Get something positive out of your participation in treatment, even if the medication you are taking does not improve your health?
High test retest reliability for Integration (r = .71) and Perseverance (r = .71). "Global composite internal reliability for the ASES was strong (q = .91; 95% CI = .89, .93) at baseline and (q = .91; 95% CI = .89, .93) at follow-up."
Concurrent and divergent validity
View article on Google Scholar
Individuals may use this information for research or educational purposes only and may not use this information for commercial purposes. When using this instrument, please cite:
Johnson, M. O., Neilands, T. B., Dilworth, S. E., Morin, S. F., Remien, R. H., & Chesney, M. A. (2007). The role of self-efficacy in HIV treatment adherence: Validation of the HIV treatment adherence self-efficacy scale (HIV-ASES). Journal of Behavioral Medicine, 30(5), 359-370.
When presenting results using any survey information you obtained from the SABI, please acknowledge the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an NIH funded program P30 AI50410.